Amarin Corp PLC (AMRN) stock
AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3061% above fair value
$11.26−0.01 (-0.09%)
Close on Nov 18, 2026Market cap $248.90MP/E –Yield –
Amarin revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Amarin's revenue for the twelve months ending Sep 30, 2026 was $176.11M, down 22.3% year over year. For fiscal 2025 it was $213.65M, down 6.5% from the year before. Over ten years it grew 10.1% a year on average. The highest annual figure on record is $614.06M in fiscal 2020.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $213.65M | -6.5% |
| FY2024 | Dec 31, 2024 | $228.61M | -25.5% |
| FY2023 | Dec 31, 2023 | $306.91M | -16.9% |
| FY2022 | Dec 31, 2022 | $369.19M | -36.7% |
| FY2021 | Dec 31, 2021 | $583.19M | -5.0% |
| FY2020 | Dec 31, 2020 | $614.06M | +42.9% |
| FY2019 | Dec 31, 2019 | $429.76M | +87.5% |
| FY2018 | Dec 31, 2018 | $229.21M | +26.6% |
| FY2017 | Dec 31, 2017 | $181.10M | +39.2% |
| FY2016 | Dec 31, 2016 | $130.08M | +59.1% |
| FY2015 | Dec 31, 2015 | $81.76M | +50.8% |
| FY2014 | Dec 31, 2014 | $54.20M | +105.7% |
| FY2013 | Dec 31, 2013 | $26.35M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $39.55M | -20.4% |
| Q2 FY2026 | Jun 30, 2026 | $42.21M | -42.0% |
| Q1 FY2026 | Mar 31, 2026 | $45.13M | +7.4% |
| Q4 FY2025 | Dec 31, 2025 | $49.22M | -21.0% |
| Q3 FY2025 | Sep 30, 2025 | $49.67M | +17.4% |
| Q2 FY2025 | Jun 30, 2025 | $72.74M | +7.8% |
| Q1 FY2025 | Mar 31, 2025 | $42.02M | -25.7% |
| Q4 FY2024 | Dec 31, 2024 | $62.31M | -16.6% |
| Q3 FY2024 | Sep 30, 2024 | $42.30M | -36.0% |
| Q2 FY2024 | Jun 30, 2024 | $67.49M | -15.8% |
| Q1 FY2024 | Mar 31, 2024 | $56.52M | -34.3% |
| Q4 FY2023 | Dec 31, 2023 | $74.71M | -17.2% |
| Q3 FY2023 | Sep 30, 2023 | $66.06M | -26.5% |
| Q2 FY2023 | Jun 30, 2023 | $80.17M | -15.1% |
| Q1 FY2023 | Mar 31, 2023 | $85.98M | -9.1% |
| Q4 FY2022 | Dec 31, 2022 | $90.25M | -37.5% |
| Q3 FY2022 | Sep 30, 2022 | $89.88M | -36.7% |
| Q2 FY2022 | Jun 30, 2022 | $94.44M | -38.9% |
| Q1 FY2022 | Mar 31, 2022 | $94.63M | -33.4% |
| Q4 FY2021 | Dec 31, 2021 | $144.49M | -13.6% |
| Q3 FY2021 | Sep 30, 2021 | $142.04M | -9.2% |
| Q2 FY2021 | Jun 30, 2021 | $154.49M | +14.2% |
| Q1 FY2021 | Mar 31, 2021 | $142.17M | -8.3% |
| Q4 FY2020 | Dec 31, 2020 | $167.25M | +16.7% |
| Q3 FY2020 | Sep 30, 2020 | $156.50M | +39.2% |
| Q2 FY2020 | Jun 30, 2020 | $135.32M | +34.3% |
| Q1 FY2020 | Mar 31, 2020 | $154.99M | +111.5% |
| Q4 FY2019 | Dec 31, 2019 | $143.28M | +85.3% |
| Q3 FY2019 | Sep 30, 2019 | $112.41M | +103.2% |
| Q2 FY2019 | Jun 30, 2019 | $100.79M | +91.5% |
| Q1 FY2019 | Mar 31, 2019 | $73.28M | +66.8% |
| Q4 FY2018 | Dec 31, 2018 | $77.33M | +43.6% |
| Q3 FY2018 | Sep 30, 2018 | $55.32M | +16.8% |
| Q2 FY2018 | Jun 30, 2018 | $52.64M | +16.4% |
| Q1 FY2018 | Mar 31, 2018 | $43.92M | +26.8% |
| Q4 FY2017 | Dec 31, 2017 | $53.87M | +39.2% |
| Q3 FY2017 | Sep 30, 2017 | $47.36M | – |
| Q2 FY2017 | Jun 30, 2017 | $45.24M | – |
| Q1 FY2017 | Mar 31, 2017 | $34.64M | – |
| Q4 FY2016 | Dec 31, 2016 | $38.70M | – |
See a number that looks wrong?